Skip to main content
. Author manuscript; available in PMC: 2021 Jul 25.
Published in final edited form as: Mov Disord. 2020 Feb 24;35(6):976–983. doi: 10.1002/mds.28007

TABLE 3.

Cutoffs and diagnostic properties of MRPI for the differentiation of patients with PSP from non-PSP participants

Cutoff and statistical values Automated MRPI

164 PSP vs 452 non-PSP
Cutoff value > 13.42
Sensitivity 82.3%
Specificity 93.8%
Accuracy 90.7%
PPV 82.8%
NPV 93.6%
108 PSP-RS vs 452 non-PSP
Cutoff value ≥ 13.88
Sensitivity 88.9%
Specificity 94.7%
Accuracy 93.6%
PPV 80.0%
NPV 97.3%
56 PSP-P vs 452 non-PSP
Cutoff value ≥ 12.38
Sensitivity 76.8%
Specificity 87.6%
Accuracy 86.5%
PPV 43.4%
NPV 96.8%

PSP, progressive supranuclear palsy; PSP-P, progressive supranuclear palsy–parkinsonism; PSP-RS, progressive supranuclear palsy–Richardson’s syndrome; non-PSP, Parkinson’s disease patients + multiple system atrophy patients + healthy controls; MRPI, Magnetic Resonance Parkinsonism Index; PPV, positive predictive value; NPV, negative predictive value.